Loading company…
Proteinea uses AI and computational tools to engineer therapeutic antibodies.
Proteinea designs antibody components for biopharmaceutical companies and research institutions. Its work includes antibody Fc domains intended to influence immune responses and drug distribution. Founded in 2019, the company is based in Cairo, Egypt. It received a USD 0.09 mn Grant led by Changelabs on February 26, 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in